Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 3
2005 2
2006 3
2007 2
2008 5
2009 6
2010 5
2011 6
2012 12
2013 8
2014 3
2015 7
2016 6
2017 12
2018 10
2019 8
2020 10
2021 9
2022 10
2023 4
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. Among authors: nyholm d. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.
Svenningsson P, Odin P, Bergquist F, Wirdefeldt K, Nyholm D, Andréasson M, Markaki I, Johansson AC, Jergil M, Jankosky C, Varney MA, Herbrecht F, Johnson SA, Newman-Tancredi A. Svenningsson P, et al. Among authors: nyholm d. Mov Disord. 2025 Jun;40(6):1134-1142. doi: 10.1002/mds.30175. Epub 2025 Mar 17. Mov Disord. 2025. PMID: 40091754 Free PMC article. Clinical Trial.
New developments in levodopa therapy.
LeWitt PA, Nyholm D. LeWitt PA, et al. Among authors: nyholm d. Neurology. 2004 Jan 13;62(1 Suppl 1):S9-16. doi: 10.1212/wnl.62.1_suppl_1.s9. Neurology. 2004. PMID: 14718676 Review.
A survey of lifestyle factors in dystonia.
Söderlund J, Nyholm D. Söderlund J, et al. Among authors: nyholm d. Brain Behav. 2020 Dec;10(12):e01871. doi: 10.1002/brb3.1871. Epub 2020 Oct 6. Brain Behav. 2020. PMID: 33025722 Free PMC article.
124 results